that info locked by the CEO. Direct your Q to him
without an update by this week -many will sell to bring pps further down.
hate commpanies whos management plays ego game and keeps investors in the dark.
bad: that it is down almost 100% from high of yestarday and definitely pinches hard
good: this will go back up with the real news and second the gap at 64 got nicely filled and ended the day in good note
Don't be out of luck. still time- it might open where it closed today. this thing is destined to be huge. if everything goes as in their plan this will see easy 1000% from here. next one will join in line with ELRA IS BETS
Both ELRA & BETS has 1000% + potential in SHORT RUN (week-2month) GL
CEO buying up the float - R U KIDDING
CEO taking all his pay in shares: GUESS HE COULDN'T FIND A JOB THAT PAYS IN CASH? HE MUST BE A DESPARATE FELLOW -
tried to understand the logistic and ... of this company -
nothing clear about that $4 price tag, so taking the high road
my starter 50k share going out the door today - lets see where it goes
'll consider again when eltp start talking sense about that $4 and those eltp bottles start getting filled with real medicine.
RGs recent activities/PR give NO INDICATION OF deal, it may need much time if at al.
But right now another cloud technology company coming up fast is TPNI
TPNI imo will out perform YIPI
TPNI low float promising technology
Look at their publication record in last one year alone:
Hum Vaccin Immunother. 2013 Mar 6;9(6).
J Virol 2013 Jun;87(12):6560-8. doi: 10.1128/JVI.00635-13.
PLoS One 2013;8(2):e55571. doi: 10.1371/journal.pone.0055571.
Lancet Infect Dis 2013 Jan;13(1):18. doi: 10.1016/S1473-3099(12)70296-7.
Hum Vaccin Immunother 2012 Dec 1;8(12):1764-8. doi: 10.4161/hv.21806.
Cancer Gene Ther 2012 Dec;19(12):811-7. doi: 10.1038/cgt.2012.69.
Hum Vaccin Immunother 2012 Nov 1;8(11):1595-606. doi: 10.4161/hv.21225.
Immunotherapy 2012 Nov 1; 8(11):1564-84. doi: 10.4161/hv.22129.
Vaccine 2012 Nov 19;30 (49):7046-51. doi: 10.1016/j.vaccine.2012.09.057.
these are in public domen now, add to that add the IPs (patent and trade secrects) and the clinical pipeline in various phases.
for a small company like vicl this is impressive and of high value, current PPS is temporary
and just in a matter of time it will be readjusted IMO.
But for now it is time to take profit - no deal PRd and seems not in at least a month- meanwhile it will go back some tomorrow and next 2-6 weeks- suspecting some dilution